Join the club for FREE to access the whole archive and other member benefits.

Betalin Therapeutics

Develops Engineered Micro-Pancreas (EMP) as a cell therapy solution for insulin-dependent diabetes

Betalin Therapeutics is developing the next generation of insulin-producing cell transplantation providing a solution for insulin-dependent diabetic people using tissue engineering.

Betalin developed a unique  micro organ scaffold that uses natural de-cellularized ECM, derived from natural tissue, to support the long term function of  β-cells.

Visit website:

People at Betalin Therapeutics

Company Representative

CEO at Betalin Therapeutics

Betalin Therapeutics News

Engineered Micro-Pancreas (EMP) could rectify diabetes

Guardian - 23-Jul-2020

Betalin's biological scaffold holds beta cells that release insulin instead of having to inject it